Profound Medical Showcases TULSA-PRO in Seven Sessions at SIR Meeting
Profound Medical will present its TULSA-PRO system in seven sessions at the Society of Interventional Radiology’s 2026 Annual Scientific Meeting, showcasing procedural protocols and clinical case outcomes. This heightened exposure could accelerate adoption of its MRI-guided prostate ablation platform and support broader commercial traction.
1. Conference Presentations
Profound Medical will highlight its TULSA-PRO MRI-guided transurethral prostate ablation system across seven presentations at the 2026 Society of Interventional Radiology Annual Scientific Meeting, showcasing procedural protocols, device performance metrics and real-world case outcomes to an audience of leading interventional radiologists.
2. Potential Impact on Adoption
By delivering detailed clinical data and technique demonstrations at a premier industry event, Profound Medical aims to accelerate professional endorsement, stimulate referral patterns and support discussions with payers to expand the commercial footprint of its TULSA-PRO platform.